Carter’s Operating Income Jumps 91.7% to $55.8 Million Despite Lower Sales
Key Facts
Carter’s reported on October 30 that operating income for the third quarter of fiscal 2026 rose 91.7% to $55.8 million, compared with $29.1 million a year earlier, while net sales fell 0.7% to $752.5 million from $757.8 million. Operating margin increased to 7.4% from 3.8% in the year-earlier period, while net income was $36.6 million, or $1.00 per diluted share, compared with $11.6 million and $0.32 per share a year earlier. Chief Executive Sharon Price John said total net sales came in slightly above the company’s expectations amid a mixed macroeconomic environment. She added that the company lowered its revenue outlook because of continued pressure on consumers amid economic and geopolitical uncertainty. The results show improved profitability alongside a slight decline in quarterly revenue.
The company attributed the improvement in operating income to higher realized pricing and benefits from productivity initiatives, as well as the absence of restructuring and operating-model optimization costs recorded the previous year. These factors were partly offset by increased marketing investment and broad-based cost inflation. By sales channel, the international business segment grew 4.5%, while U.S. retail sales were flat year over year. U.S. wholesale sales fell 3.8%, while comparable U.S. retail sales rose 0.4%. Price John said comparable U.S. retail sales and total net sales posted modest growth, while net sales came in slightly above the company’s expectations.
In the first three quarters of fiscal 2026, net sales rose 3.9% to $2.05 billion, compared with $1.97 billion in the same period a year earlier. Operating cash flow was $101.8 million, compared with net cash usage of $136.3 million in the year-earlier period. The company attributed the improvement mainly to receiving a refund of previously paid import duties and improved working capital. The nine-month results also included a benefit related to the recovery of import duties and interest, alongside leadership transition costs and intellectual property litigation. The company’s fiscal-year outlook assumptions include a recovery of $132 million in duties and interest, expected adjustments of approximately $8 to $9 million for leadership transition and litigation costs, and a slight decline in gross margin.
Carter’s set a net sales range of $2.91 billion to $2.93 billion for fiscal 2026, compared with $2.898 billion in fiscal 2025, which lasted 53 weeks. It expects adjusted operating income of $178 million to $187 million, versus $176 million in the prior year. Adjusted diluted earnings per share are expected to be between $3.05 and $3.23, after $3.47 in 2025. For the fourth quarter, it set a range for adjusted operating income of $74 million to $83 million, compared with $89 million in the year-earlier period. It also expects adjusted diluted earnings per share of $1.37 to $1.55 for the quarter, versus $1.90 in the fourth quarter of fiscal 2025.
The company said it launched a comprehensive Carter’s brand initiative during the quarter, including a redesigned logo and a brand promise, “Let Every Child Shine,” in the first comprehensive initiative of its kind in 25 years, according to the chief executive. Management changes included the appointment of Maria Gimzel as chief product officer, with her arrival expected in early 2027, and Alison Peterson as chief commercial officer. The company also created a separate chief operating officer position and began searching for a candidate, and expanded Emily Everett’s responsibilities to include strategy, business development, consumer insights and international business. Sarah Crockett was appointed chief brand officer, while Julie DeMilio will retire after serving as an adviser during the transition through year-end, and Karen Smith plans to retire in March 2027. The company paid total cash dividends of $27.5 million in the first three quarters, with no share buybacks; its stock closed at $33.38 on October 29, before the results were announced.